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Introduction: Although obesity is a risk factor for hip osteoarthritis (OA), the role of body composition, if any, is
unclear. This study examines whether the body mass index (BMI) and body composition are associated with hip
cartilage changes using magnetic resonance imaging (MRI) in community-based adults.
Methods: 141 community-based participants with no clinical hip disease, including OA, had BMI and body
composition (fat mass and fat free mass) measured at baseline (1990 to 1994), and BMI measured and 3.0 T MRI
performed at follow-up (2009–2010). Femoral head cartilage volume was measured and femoral head cartilage
defects were scored in the different hip regions.
Results: For females, baseline BMI (β = −26 mm3, 95% Confidence interval (CI) -47 to −6 mm3, p = 0.01) and fat
mass (β = −11 mm3, 95% CI −21 to −1 mm3, p = 0.03) were negatively associated with femoral head cartilage
volume. Also, while increased baseline fat mass was associated with an increased risk of cartilage defects in the
central superolateral region of the femoral head (Odds Ratio (OR) = 1.08, 95% CI 1.00–1.15, p = 0.04), increased
baseline fat free mass was associated with a reduced risk of cartilage defects in this region (OR = 0.82, 95% CI
0.67–0.99; p = 0.04). For males, baseline fat free mass was associated with increased femoral head cartilage volume
(β = 40 mm3, 95% CI 6 to 74 mm3, p = 0.02).
Conclusions: Increased fat mass was associated with adverse hip cartilage changes for females, while increased fat
free mass was associated with beneficial cartilage changes for both genders. Further work is required to determine
whether modifying body composition alters the development of hip OA.Introduction
Osteoarthritis (OA) of the hip and knee are common
and painful conditions that often require costly joint re-
placement surgery for end-stage disease. Most studies
examining the pathogenesis of OA have focussed on
cartilage as the primary endpoint, predominantly via
examining radiographic joint space width as an indirect
measure of articular cartilage. It is now well-recognised
that radiographic joint space narrowing is a relatively
late sign of hip OA, with a 13% mean reduction in fem-
oral head cartilage volume occurring by the time the* Correspondence: Flavia.cicuttini@monash.edu
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creativecommons.org/publicdomain/zero/1.0/first changes in radiographic joint space narrowing be-
come present [1].
With the advent of magnetic resonance imaging (MRI),
it is possible to directly examine articular cartilage. Cartil-
age defects represent localised cartilage pathology and
predict pain, cartilage volume loss and joint replacement
surgery at the knee [2-4]. Cartilage defects are not as well-
studied at the hip, but have been associated with self-
reported pain, disability and radiographic OA [5,6]. By
examining risk factors that are associated with early struc-
tural hip changes such as reduced cartilage volume and
the presence of cartilage defects, it may be possible to bet-
ter understand early pathological processes and develop
interventions that aim to avert or delay the development
and/or progression of hip OA.article distributed under the terms of the Creative Commons Attribution
by/4.0), which permits unrestricted use, distribution, and reproduction in any
ly cited. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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for knee OA [7-9], the relationship between obesity and
hip OA is less consistent [10-15]. The most commonly
employed measure of obesity is the body mass index
(BMI), which has been shown to predict hip replacement
[16] but BMI fails to account for body composition and
cannot discriminate adipose from non-adipose body
mass [17]. At the knee, body composition studies have
shown a detrimental effect of fat mass and a beneficial
effect of fat-free mass on knee cartilage [18-20], with a
recent systematic review concluding that fat mass is asso-
ciated with the early structural changes of cartilage defects
[21]. At the hip, adiposity measures such as fat mass have
been shown to be associated with an increased risk of hip
joint replacement [16] but there are no data available to
examine whether body composition is associated with
structural changes at the hip.
The aim of this study was to examine associations
between BMI and body composition (fat and fat-free
mass) and femoral head cartilage volume and defects in
community-based adults with no diagnosed hip OA.Methods
Participants
One hundred and forty-one people with no diagnosed
hip OA were recruited between 2009 and 2010 from the
Melbourne Collaborative Cohort Study (MCCS), a pro-
spective cohort study of residents of Melbourne, Australia,
aged 40 to 69 years at MCCS inception (1990 to 1994)
[22]. Participants were eligible for the current study if they
were aged 50 to 85 years without any of the following ex-
clusion criteria: a medical or allied health professional diag-
nosis of hip OA; significant hip pain lasting for >24 hours
in the last 5 years; a previous hip injury requiring non
weight-bearing treatment for >24 hours or surgery (in-
cluding arthroscopy); or a history of any form of arth-
ritis diagnosed by a medical practitioner. Participants
were further excluded if they had any malignancy or any
contraindication to MRI, including a pacemaker, metal
sutures, presence of shrapnel or iron filings in the eye,
or claustrophobia. The study was approved by the Human
Research Ethics Committees of The Cancer Council
Victoria and Monash University. All participants gave
written informed consent.Anthropometric data
Height and weight were measured at baseline assessment
during 1990 to 1994 and repeated at the time of hip
MRI during 2009 to 2010. Weight was measured to the
nearest 100 g using digital electronic scales. Height was
measured to the nearest 1 mm using a stadiometer. BMI
was calculated as the weight in kilograms divided by the
square of height in meters.Body composition measures
Bioelectric impedance analysis was performed at baseline
(1990 to 1994) with a single-frequency (50 kHz) electric
current produced by a BIA-101A RJL system analyser
(RJL systems, Detroit, MI, USA) during 1990 to 1994. Re-
sistance and reactance were measured with subjects in the
supine position. The non-adipose mass, hereafter termed
fat-free mass, was estimated [23] in male subjects as:
9.1536 + (0.4273 × Height2/Resistance) + (0.1926 ×
Weight) + (0.0667 × Reactance).
Fat-free mass in female subjects was estimated as:
7.7435 + (0.4542 × Height2/Resistance) + (0.119 ×
Weight) + (0.0455 × Reactance).
The adipose mass, hereafter termed fat mass (FM).
FM was calculated as:
FM =Weight – Fat-free mass.
Body-fat percentage was calculated by dividing FM by
weight and multiplying by 100.
MRI measurements
Each participant had MRI performed on their dominant
hip, defined by the leg used to kick a ball (89% right
sided), during 2009 to 2010, an average of 16.9 (±0.61)
years after MCCS inception. Hips were imaged on a 3.0-
T whole body magnetic resonance unit (Siemens, Verio,
Siemens Medical, Germany) using a phased array flex
coil. Sagittal images were obtained using a T2-weighted
fat-suppressed three-dimensional gradient-recalled ac-
quisition sequence in the steady state (repetition time
14.45 msec, echo time 5.17 msec; flip angle 25°, slice
thickness 1.5 mm, field of view 16 cm, pixel matrix
320 × 320, acquisition time 7 minutes 47 seconds, and one
acquisition). Coronal images were obtained using a fat sat-
uration, proton density, spin-echo acquisition sequence
(repetition time 3,400 msec, echo time 64 msec, flip angle
90°, slice thickness 3 mm, field of view 16 cm, pixel
matrix 256 × 256, acquisition time 5 minutes 26 sec, and
one acquisition).
Femoral head cartilage volume was measured from T2-
weighted sagittal images using the software Osiris (version
4.19; Geneva University Hospital, Geneva, Switzerland) as
previously described [1]. The image data were transferred
to the workstation, and an isotropic voxel size was then
obtained by a trilinear interpolation routine. The volume
of the femoral head cartilage was isolated from the total
volume by drawing disarticulation contours around the
cartilage boundaries on each image section. These data
were then resampled by bilinear and cubic interpolation
for the final three-dimensional rendering. The volume of
the femoral head cartilage was determined by summing all
the pertinent voxels within the resultant binary volume.
Femoral head cartilage volume was measured in duplicate
with at least a one-week interval by one trained observer.
The coefficient of variation (CV) was 2.5% [1]. The intra-
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ation coefficient, ICC) was 0.99.
The femoral head was divided into three regions: cen-
tral, anterior and femoral to assess cartilage defects. The
anterior and posterior regions were assessed in the sagit-





Figure 1 Regional zones of the hip joint. (A) Sagittal image depicting the
central superolateral (CSL) and inferomedial (CIM) regions.coronal slices (9 mm) (Figure 1A). The area in between
the anterior and posterior region was termed the central
region. Femoral head cartilage defects were assessed from
proton density coronal images and confirmed on sagittal
imaging for the central region, and from the sagittal im-




anterior, central and posterior regions. (B) Coronal image depicting the
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ness of more than 50% which was shown on at least two
consecutive slices. One trained observer, who was blinded
to participants’ characteristics, assessed the presence of
cartilage defects for each participant in duplicate, at least
one week apart. The intra-observer reproducibility (ICC)
was 0.72. The central region was further subdivided in the
coronal plane (Figure 1B). The intersection of the axis of
the femoral head and neck was considered to be the mid-
point of the region, with the axis of the femoral neck used
to demarcate the central superolateral from the central
inferomedial region. The division of anterior, central and
posterior regions was adapted from methods used in pre-
viously published works [5,6].
The sagittal image closest to the centre of the femoral
head was used to measure the femoral head bone area.
It was measured by drawing contours around the fem-
oral head bone, and the area was calculated automatic-
ally by the Osiris program as an indicator of bone size.
Femoral head bone area was measured by one trained
observer with 50 random cross-checks performed by a
second observer. The CV was 1.1% [1]. The inter-observer
reproducibility (ICC) was 0.99.
Statistical analyses
Multiple linear regression analyses were used to determine








Body mass index, kg m−2 27.2 (3.5) 25.1 (4.2) <0.01
Fat mass, kg 24.2 (7.7) 25.0 (8.9) 0.59
Body fat, % 28.8 (6.1) 37.3 (7.0) <0.001
Fat-free mass, kg 58.3 (5.0) 40.3 (3.6) <0.001
Follow-up measurements (2009
to 2010)
Age, years 66.2 (6.8) 67.2 (7.8) 0.41
Body mass index, kg m−2 28.3 (4.1) 27.0 (5.3) 0.09
WOMAC median pain, out of 500 19 22 -
Femoral head cartilage volume, mm3 3891 (636) 2867 (451) <0.001
Femoral head bone area, mm2 1831 (179) 1429 (126) <0.001
Femoral head cartilage defects, n (%)
Central superolateral 22 (35.5) 23 (29.1) 0.422
Central inferomedial 30 (48.4) 37 (46.8) 0.862
Anterior 4 (6.3) 1 (1.3) 0.102
Posterior 11 (17.5) 14 (17.7) 0.972
Data presented as mean (standard deviation) or number (%) unless otherwise
stated. 1P-values represent difference between genders analysed by
independent sample t-tests unless otherwise stated. 2Chi-squared test.
WOMAC, Western Ontario and McMaster University osteoarthritis index.measures with femoral head cartilage volume. Binary lo-
gistic regression was used to determine the relationships
between femoral head cartilage defects and BMI and body
composition measures. Because body composition and
femoral head cartilage volume differed significantly be-
tween men and women, genders were examined separ-
ately, with adjustments for age, femoral head bone area
and another marker of body composition. For instance,
when fat mass was the independent variable, fat-free mass
was adjusted for in multivariate analyses. In contrast,
when fat-free mass was the independent variable, fat mass
was adjusted for in multivariate analyses. To examine
whether there was multicolinearity between fat-free
mass and fat mass, we performed a colinearity diagnosis.
In men, the Pearson correlation between fat-free mass
and fat mass was 0.39, with the tolerance of 0.80 for
both fat-free mass and fat mass. In women, the Pearson
correlation was 0.40, with the tolerance of 0.68 for fat-
free mass and 0.78 for fat mass. Therefore, there was no
multicolinearity between fat-free mass and fat mass and
it is appropriate to co-adjust fat mass and fat-free mass
in one model. A P-value <0.05 (two-tailed) was regarded
as statistically significant. All analyses were performed
using the SPSS statistical package (standard version 20.0
SPSS, Chicago, IL, USA).
Results
Subject characteristics are shown in Table 1. Men had
greater BMI, femoral head cartilage volume and bone
area as well as fat-free mass than women (all P <0.01).
In contrast, women had greater percentage of body fat
than men (37.3% versus 28.8%, P <0.001). There was no
difference between genders in fat mass or prevalence of
femoral head cartilage defects. The prevalence of cartilage
defects in the anterior (6.5% versus 1.2%, men to women)
and posterior (17.7% versus 17.7%, men to women) region
of the femoral head was low for both genders. The median
of the total Western Ontario and McMaster University
osteoarthritis index (WOMAC) pain score (out of 500)
was 19 for men and 22 for women (P = 0.36, Mann–
Whitney U-test).
The relationships between BMI and body composition
measures and femoral head cartilage volume are shown
in Table 2. After adjusting for age and femoral head bone
area, BMI at baseline was negatively associated with
femoral head cartilage volume in women (β -26 mm3,
95% CI −47 to −6 mm3, P = 0.01), but not men (β 3 mm3,
95% CI −37 to 44 mm3, P = 0.87). That is, for every one
unit increase in BMI (kg m−2), there was an associated
26 mm3 reduction in femoral head cartilage volume in
women. BMI at baseline was strongly correlated with BMI
at follow up (time of MRI) (r = 0.86, P <0.0001), while
greater BMI at follow up tended toward being associ-
ated with reduced femoral head cartilage volume for












(95% CI) (95% CI) (95% CI) (95% CI)
1990 to 1994
BMI1, kg m−2 1 (−47, 49) 0.96 3 (−37, 44) 0.87 −28 (−52, −4) 0.02 −26 (−47, −6) 0.01
Fat-free mass2, kg 46 (15, 78) <0.01 40 (6, 74) 0.02 15 (−14, 43) 0.30 0 (−29, 29) 0.98
Fat mass3, kg 13 (−8, 35) 0.22 −3 (−24, 17) 0.73 −8 (−19, 4) 0.17 −11 (−21, −1) 0.03
Body fat3, % 4 (−24, 32) 0.78 −6 (−30, 17) 0.60 −13 (−28, 1) 0.08 −13 (−26, 0) 0.04
2009 to 2010
BMI1, kg m−2 1 (−46, 49) 0.95 9 (−30, 49) 0.65 −22 (−40, −3) 0.03 −15 (−32, 1) 0.06
1Adjusted for age and femoral head bone area. 2Adjusted for age, femoral head bone area, and fat mass. 3Adjusted for age, femoral head bone area and fat-free
mass. BMI, body mass index.
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After adjusting for age, femoral head bone area and
fat-free mass, greater fat mass (β -11 mm3, 95% CI −21
to −1 mm3, P = 0.03) and percentage body fat (β -13 mm3,
95% CI −26 to −0 mm3, p = 0.04) at baseline were both as-
sociated with reduced femoral head cartilage volume in
women. Fat-free mass at baseline was positively associated
with femoral head cartilage volume in men (β 40 mm3,






(95% CI) (95% CI)
Central superolateral
1990 to 1994
Body mass index1, kg m−2 1.05 (0.91, 1.22) 0.50 1.05 (0.90, 1.22)
Fat-free mass2, kg 1.06 (0.95, 1.18) 0.28 1.06 (0.94, 1.20)
Fat mass3, kg 1.01 (0.94, 1.08) 0.83 0.99 (0.91, 1.06)
Body fat3, % 1.01 (0.93, 1.11) 0.75 1.00 (0.92, 1.10)
2009 to 2010
Body mass index1, kg m−2 1.02 (0.90, 1.16) 0.76 1.02 (0.90, 1.16)
Central inferomedial
1990 to 1994
Body mass index1, kg m−2 1.11 (0.95, 1.28) 0.19 1.11 (0.96, 1.29)
Fat-free mass2, kg 1.08 (0.97, 1.20) 0.17 1.12 (0.99, 1.27)
Fat mass3, kg 0.98 (0.92, 1.03) 0.56 0.96 (0.89, 1.04)
Body fat3, % 0.95 (0.87, 1.04) 0.25 0.95 (0.87, 1.04)
2009 to 2010
Body mass index1, kg m−2 1.13 (0.99, 1.29) 0.08 1.12 (0.98, 1.28)
1Adjusted for age and femoral head bone area. 2Adjusted for age, femoral head bo
fat-free mass.0 mm3, 95% CI −29 to 29 mm3, P = 0.98) after adjustment
for age, femoral head bone area and fat mass.
The relationships between BMI and body composition
measures and femoral head cartilage defects are shown
in Table 3. After adjusting for age, femoral head bone
area and fat-free mass, increased fat mass at baseline
was associated with an increased risk of cartilage defects
in the central superolateral region of the femoral head in
women (OR 1.08, 95% CI 1.00 to 1.15, P = 0.04) but notposition measures and femoral head cartilage defects
Women





(95% CI) (95% CI)
0.53 1.09 (0.97, 1.22) 0.14 1.08 (0.96, 1.21) 0.21
0.31 0.93 (0.81, 1.07) 0.32 0.82 (0.67, 0.99) 0.04
0.71 1.04 (0.99, 1.10) 0.15 1.08 (1.00, 1.15) 0.04
0.94 1.07 (0.99, 1.15) 0.07 1.08 (0.99, 1.17) 0.07
0.73 1.06 (0.97, 1.16) 0.19 1.07 (0.97, 1.17) 0.18
0.16 1.00 (0.90, 1.11) 0.96 0.99 (0.88, 1.10) 0.82
0.07 1.00 (0.89, 1.14) 0.97 0.96 (0.83, 1.12) 0.63
0.35 1.02 (0.97, 1.07) 0.50 1.02 (0.96, 1.08) 0.51
0.28 1.03 (0.96, 1.10) 0.40 1.03 (0.96, 1.10) 0.48
0.08 1.01 (0.93, 1.10) 0.83 1.01 (0.93, 1.10) 0.80
ne area and fat mass. 3Adjusted for age, femoral head bone area and
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fat-free mass at baseline was associated with a reduced
risk of prevalent cartilage defects in the central supero-
lateral region of the femoral head in women (OR 0.82,
95% CI 0.67 to 0.99; P = 0.04) but not men (OR 1.02,
95% CI 0.93, 1.11, P = 0.70) after adjusting for age,
femoral head bone area and fat mass. There were no sig-
nificant associations between BMI and femoral head
cartilage defects, or between body composition mea-
sures and cartilage defects in the central inferomedial
region of the femoral head. The low prevalence of cartil-
age defects at the anterior femoral head in this cohort
precluded analyses for this region, and there was no sig-
nificant associations found for cartilage defects at the
posterior femoral head (data not shown).
Discussion
Increased fat mass was associated with adverse hip car-
tilage changes in women (reduced cartilage volume and
increased cartilage defects), while increased fat-free mass
was associated with beneficial cartilage changes in both
genders (reduced cartilage defects in the central supero-
lateral region of the femoral head in women; increased
femoral head cartilage volume in men). Further work is
required to determine whether modifying body compos-
ition alters the natural history of hip OA.
This is the first study to directly examine associations
between adiposity and hip cartilage volume and defects.
A previous systematic review concluded that obesity
(measured predominantly by increased BMI) had a mod-
erately positive influence on the development of hip OA,
with an odds ratio of approximately two [15]. Neverthe-
less, previous studies have relied upon radiographic joint
space narrowing, an indirect measure of cartilage loss, to
assess the relationship between obesity and hip OA
[10-15]. In the current study, we measured femoral head
cartilage volume from MRI. Previously it has been shown
that a diminution in cartilage volume predates radio-
graphic joint space narrowing [1]. We found that an in-
creased BMI was associated with reduced femoral head
cartilage volume for women. As BMI is an indirect and
surrogate measure that cannot discriminate adipose from
non-adipose mass, we also examined the association of
body composition and found that measures of adiposity
(fat mass and percentage of body fat) were associated with
reduced femoral head cartilage volume in women, but not
men. In contrast, increased fat-free mass was associated
with increased femoral head cartilage volume in men.
This study also found that increased fat mass was as-
sociated with an increased risk of prevalent cartilage de-
fects in the central superolateral region of the femoral
head for women. There is evidence that the location of
cartilage defects within the hip joint may be important,
with greater self-reported disability shown to be associatedwith lesions in the superior location of the hip, a region
comparable to our definition of central superolateral [5].
Consistently, we found that in women increased fat mass
was associated with an increased risk, while increased fat-
free mass was associated with a reduced risk of cartilage
defects in the central superolateral but not the central
inferomedial region of the femoral head. Even among
people with no diagnosed hip OA, cartilage defects are as-
sociated with reduced femoral head cartilage volume, a
structural hallmark that demarcates people with and with-
out hip OA [24]. Therefore, the results of this study, even
in a population with no diagnosed hip OA, likely repre-
sent very early structural joint damage.
The mechanisms by which an increased BMI and fat
mass adversely affects hip cartilage is unknown. It is
possible that deleterious structural changes may in part
be due to excessive loading of the hip joint caused by in-
creased body mass. For instance, through altered joint
biomechanics, obesity may remodel hip bone. In turn,
abnormal bone geometry could act as an intermediary be-
tween obesity and cartilage damage. It is well-established
that people with abnormal hip bone shape (for example,
femoroacetabular impingement) have greater cartilage
damage than healthy controls [25]. Clarifying the role of
bone geometry as a potential intermediate step is complex
as there are a number of different measures that may be
used to assess hip bone shape. This was highlighted in a
recent review discussing that there is accumulating evi-
dence that the aetiology of hip OA may be due to more
subtle abnormalities of the proximal femur and acetabu-
lum [26]. As there may be gender differences in hip bone
shape, we have presented gender-specific analyses to deal
with any such differences. Acetabular over-coverage (pin-
cer deformity), which is more common in women than
men [27], may be one mechanism mediating the associ-
ation between obesity/adiposity and cartilage damage in
women. Nevertheless, whether the central superolateral
region of the hip joint is vulnerable to biomechanical
damage, such as that imparted by added loading from
obesity, is speculative but there is evidence that the effect
of obesity on OA cannot simply be explained by mechan-
ical loading. For example, it has long been recognized that
obesity is a risk factor for hand OA [28]. Furthermore,
adipose tissue that was previously considered to be a
passive store of energy is now recognised as a highly
metabolic organ releasing various pro-inflammatory cy-
tokines including tumour necrosis factor alpha and
interleukin-1, both of which have been postulated to
play a key role in cartilage destruction in OA [29,30].
Thus, clarifying the relative contribution of joint loading
and meta-inflammation in obesity will be important in
optimizing early prevention and treatment of hip OA.
In contrast to fat mass, muscle mass has been shown
to be protective against cartilage loss at the knee [31].
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between body composition and hip cartilage properties.
This study has shown that increased fat-free mass is as-
sociated with a reduced risk of prevalent hip cartilage
defects in women and with increased femoral head car-
tilage volume in men. It may be that increased muscle
mass promotes joint stability and protects against dele-
terious cartilage changes. Nevertheless, this study has
only examined total fat-free mass and has not investi-
gated local muscle mass.
Moreover, an important observation of this study was
that the associations between fat mass and cartilage
change were significant for women, but not for men.
This will need to be confirmed by larger studies but sug-
gests that the influence of BMI and body composition
on cartilage is weaker for men than women. This may be
partly attributable to the lower percentage of body fat
observed in men, as well as the smaller sample of men
in this series. However, our data may also support the
idea that there are gender differences in risk factors for
OA. Previous studies at the knee have demonstrated a
similar gender disparity, whereby adiposity measures
have been shown to be associated with cartilage path-
ology in women only [19,20,32]. Hormonal influences
may be important in explaining potential gender differ-
ences, although the average age of the women at the
time of MRI assessment in this study was 67.2 years. Thus
it is likely that the women in this study were postmeno-
pausal at the time of MRI, mitigating hormonal differ-
ences between women and men of this age. Acetabular
over-coverage (pincer deformity), which is more common
in women than men [27], may be another mechanism
mediating the association between obesity/adiposity and
cartilage damage in women. Regardless of the under-
lying mechanism, these results suggest that gender dif-
ferences need to be considered in the prevention and
treatment of hip OA.
This study has several limitations. A larger study with
more men is needed to clarify the gender differences in
the relationships between obesity and body composition
measures and femoral head cartilage properties. More-
over, radiographs were not performed in this study.
Some subjects may have had early radiographic OA. On
the other hand, MRI measurement of hip cartilage
volume is sensitive and correlates with radiographic hip
OA [1], likely attenuating any influence that radiographic
disease may have had. Additionally, we recruited a sam-
ple with no diagnosis of hip OA. Although we did not
perform any clinical assessment, we found that the
WOMAC pain index median score was very low (19 for
men and 22 for women, out of a total possible of 500),
providing further evidence to support that this was a
population without significant hip pain. Additionally,
obesity and body composition measures precededcartilage assessment by an average of 16.9 years in this
study. This is a strength of the study, given that the ex-
posure (body composition or obesity measures) pre-
ceded assessment of structural damage. It is unlikely
that there is reverse causation whereby deleterious
changes in hip cartilage affects body composition, as
this was a sample of individuals without significant hip
pain with presumably no activity limitations that may have
predated obesity and adiposity. Moreover in healthy popu-
lations, measures of obesity and adiposity remain stable.
We confirm this by demonstrating a strong correlation
between BMI at study inception (1990 to 1994) and when
MRI was performed an average of 16.9 years later (r =
0.86, P <0.0001). Nevertheless, BMI does not capture body
composition changes that may occur with ageing and fu-
ture studies with longitudinal body composition data are
required. It has been demonstrated that whole body fat
mass remains stable with ageing [33], supporting our con-
tention that adiposity will likely remain stable with the
passage of time in a healthy cohort such as ours, and that
the likely biggest confounder to this may be age. We have
adjusted for age in all our multivariate analyses. While the
effect of a one-unit (kgm−2) increase in BMI appears to be
associated with only a modest reduction in femoral head
cartilage volume (26 mm3) in women, the mean femoral
head cartilage volume in women was 2867 mm3. This ap-
proximates a 1% (95% CI −1.6% to −0.2%) reduction in
femoral head cartilage volume with every unit increase in
the BMI, so that a five-unit increase in BMI is associated
with approximately a 5% (95% CI −8% to −1%) reduction
in femoral head cartilage volume, independent of other
risk factors. It has previously been shown that approxi-
mately 10% of cartilage volume is lost prior to radio-
graphic joint space narrowing [1]. Subsequently, small
increases in BMI are likely to be a major determinant me-
diating the associated risk for hip OA with obesity. Fur-
thermore, although we found no statistically significant
interaction between age and either fat or fat-free mass
and femoral head cartilage volume, much larger studies
would be needed to exclude this as it may be that the ef-
fects of measures of body composition differ in younger
compared to older people. Finally, it has been notori-
ously difficult in epidemiological studies to assess struc-
tural changes at the hip joint using MRI. Our division of
the anterior, central and posterior regions was adapted
from methods used by previously published works with
smaller sample sizes [5,6] but these previous works pro-
vided no prevalence data of regional structural abnormal-
ities for comparative purposes. We have noted a low
prevalence of cartilage defects in the anterior and poster-
ior regions of the femoral head, and larger studies may be
needed to overcome this issue at the anterior and poster-
ior femoral head. Our approach has provided the first
evidence documenting the importance of the anatomical
Teichtahl et al. Arthritis Research & Therapy  (2015) 17:107 Page 8 of 9distribution of cartilage defects and their relationships
with body composition measures in the central supero-
lateral region of the femoral head.
Conclusions
We have shown that increased fat mass was associated
with adverse hip cartilage changes in women (reduced
cartilage volume and increased cartilage defects), while
increased fat-free mass was associated with beneficial
cartilage changes in both genders (reduced cartilage de-
fects in the central superolateral region of the femoral
head in women; increased femoral head cartilage volume
in men). Further work is required to determine whether
modifying body composition alters the natural history of
hip OA. Preserving or increasing fat-free mass and redu-
cing fat mass may help to reduce the incidence and pro-
gression of hip OA.
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